Latest filing published 14 Jul 2023 for Inmune Bio, Inc., €99k.
Filing timeline
BuySaleInsider track record
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Timothy j. Schroeder: trading record in brief
All filings by Timothy j. Schroeder on record concern Inmune Bio, Inc., in the capacity of board member. Between 31 March 2021 and 12 July 2023, the trades on record add up to 6 filings.
Every open-market trade on record is a sale: 6 sales worth €1.4M. So far in 2023, the count stands at no purchases and 1 sale.
The record was last updated on 14 July 2023 with an open-market sale (€99k) in Inmune Bio, Inc. Between a trade and the moment it shows up on SEC (Form 4), the median delay is 2 days. The legal deadline for a Form 4 is two business days after the transaction. A sale on its own says little: insiders also sell to pay tax, fund a purchase or diversify. These figures are compiled from regulatory filings published by SEC (Form 4). They describe what insiders did and are not a recommendation.
Companies and markets linked to Timothy j. Schroeder
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 10,000 shares@ US$11.00853.9% of flowCommon StockSEC:0001213900-23-057083:0
- 14,480 shares@ US$27.6325.7% of flowCommon StockSEC:0001213900-21-036870:0
- 30,000 shares@ US$23.20544.4% of flowCommon StockSEC:0001213900-21-036518:0
- 10,000 shares@ US$19.0211.9% of flowCommon StockSEC:0001213900-21-032529:0
- 10,000 shares@ US$17.005410.6% of flowCommon StockSEC:0001213900-21-032300:0
5 of 5 declarations